Astrazeneca AZN
NYSE AZN
$159.18 +0.57 (+0.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Cash & Current Investments (2009 - 2026)

Updated

Astrazeneca (AZN) recorded Cash & Current Investments of $4.97 billion in Q2 2026, down 30.5% from $7.15 billion a year earlier and down 34.5% from the prior quarter.

Analysis

Astrazeneca (AZN) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Astrazeneca reported Cash & Current Investments of $5.8 billion, up 4.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $5.54 billion in FY2024 (-7.0%), $5.96 billion in FY2023 (-4.7%), $6.25 billion in FY2022 (-2.5%) and $6.41 billion in FY2021 (-19.6%).
  • The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q3 2024.
  • On a year-over-year basis, Cash & Current Investments rose in four of the last eight quarters, with growth averaging 5.9%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 69.4% in Q3 2025, against a decline of 68.4% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.59 billion (Q1 2026), $5.8 billion (Q4 2025) and $8.16 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 20.76 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 6.57 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 4.89 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 3.18 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 11.70 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 7.85 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.89 Bn
Mar 31, 2026 7.56 Bn
Dec 31, 2025 5.71 Bn
Sep 30, 2025 8.14 Bn
Jun 30, 2025 7.06 Bn
Mar 31, 2025 5.40 Bn
Dec 31, 2024 5.65 Bn
Sep 30, 2024 4.80 Bn
Jun 30, 2024 6.92 Bn
Mar 31, 2024 8.02 Bn
Dec 31, 2023 5.96 Bn
Sep 30, 2023 5.12 Bn
Jun 30, 2023 5.66 Bn
Mar 31, 2023 6.46 Bn
Dec 31, 2022 6.41 Bn
Sep 30, 2022 4.90 Bn
Jun 30, 2022 4.82 Bn
Mar 31, 2022 5.82 Bn
Dec 31, 2021 6.40 Bn
Sep 30, 2021 7.15 Bn
API Access

Astrazeneca Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AZN&period=max&api_key=YOUR_API_KEY